Investor

Cleva Pharma Capital

Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series B

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque2504days00hrs00min00sec
Median round$30MRounds led0 of 1
Pitch Cleva Pharma Capital

Cleva Pharma Capital highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2019

    1 round

  2. Dec
    Pipeline TherapeuticsSeries B · US · Hadean Ventures$30MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Quick answers about Cleva Pharma Capital

What does Cleva Pharma Capital invest in?

Cleva Pharma Capital invests most often at Series B (100% of the rounds on record).

How active is Cleva Pharma Capital?

1 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019.

What has Cleva Pharma Capital invested in recently?

Its most recent investments on record: Pipeline Therapeutics (Series B, Dec 2019).

How big are Cleva Pharma Capital's cheques?

The median round it joins is $30M.

Is Cleva Pharma Capital investing now?

No investments in the last 12 months; the latest was in Dec 2019.

What kind of investor is Cleva Pharma Capital?

Cleva Pharma Capital is a growth equity firm.

Where does this information on Cleva Pharma Capital come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it